Difference between revisions of "Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][unchecked revision]
Line 4: Line 4:
 
|-
 
|-
 
!'''Disease'''!!'''Page Type'''!!'''Author'''
 
!'''Disease'''!!'''Page Type'''!!'''Author'''
−
!'''Date Assigned to Author (Target Completion Date)'''!!'''Associate Editor'''
+
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 
!'''Author Content Pending or Complete'''
 
!'''Author Content Pending or Complete'''
−
!'''Date Completed by Author'''
+
!'''Date Completed by Author'''!!'''Associate Editor'''
−
!'''Editor Reviewed (Date of Last Review)'''
+
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
 
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
 
|
 
|
−
|Fabiola Quintero-Rivera (FQR)
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|Fabiola Quintero-Rivera (FQR)
 
|
 
|
 
|
 
|
Line 21: Line 23:
 
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
 
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 30: Line 33:
 
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 39: Line 43:
 
|Gokce A. Toruner
 
|Gokce A. Toruner
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 48: Line 53:
 
|T. Niroshi  Senaratne
 
|T. Niroshi  Senaratne
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 57: Line 63:
 
|Rebecca Smith (trainee) + faculty TBD
 
|Rebecca Smith (trainee) + faculty TBD
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 66: Line 73:
 
|Mark Evans (trainee), Fabiola Quintero-Rivera
 
|Mark Evans (trainee), Fabiola Quintero-Rivera
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 75: Line 83:
 
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
 
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Mastocytosis'''''||'''''Overview'''''||
 
|'''''Mastocytosis'''''||'''''Overview'''''||
−
| ||FQR
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||FQR
 
|
 
|
 
|
 
|
Line 91: Line 101:
 
|Thuy Phung
 
|Thuy Phung
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 100: Line 111:
 
|Shashi Shetty
 
|Shashi Shetty
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 109: Line 121:
 
|Thuy Phung
 
|Thuy Phung
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 117: Line 130:
 
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 125: Line 139:
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 133: Line 148:
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 141: Line 157:
 
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
 
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 149: Line 166:
 
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
 
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 159: Line 177:
 
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
 
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|NON-WHO ENTITY
 
|NON-WHO ENTITY
Line 169: Line 188:
 
|Lauren R. Crowson (trainee) + Daynna J. Wolff
 
|Lauren R. Crowson (trainee) + Daynna J. Wolff
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|NON-WHO ENTITY
 
|NON-WHO ENTITY
Line 177: Line 197:
 
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
 
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 185: Line 206:
 
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
 
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 193: Line 215:
 
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
 
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 201: Line 224:
 
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
 
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 209: Line 233:
 
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 217: Line 242:
 
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
 
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 225: Line 251:
 
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
 
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
 
|
 
|
−
|FQR
 
 
|
 
|
 
|
 
|
 +
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 233: Line 260:
 
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
 
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 241: Line 269:
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 249: Line 278:
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 257: Line 287:
 
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 265: Line 296:
 
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 273: Line 305:
 
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
−
|FQR
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 281: Line 314:
 
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
Line 289: Line 323:
 
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|
 
|
−
|FQR
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|FQR
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
Line 304: Line 340:
 
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
 
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
 
|
 
|
−
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
 
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
 
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
 +
|
 +
|
 +
|PENDING
 
| ||JH / MS
 
| ||JH / MS
−
|PENDING
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
 
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
−
| ||JH / MS
 
−
|PENDING
 
 
|
 
|
 +
|
 +
|PENDING
 +
| ||JH / MS
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
 
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
 +
|
 +
|
 +
|PENDING
 
| ||JH / MS
 
| ||JH / MS
−
|PENDING
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
 
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
 +
|
 +
|
 +
|PENDING
 
| ||JH / MS
 
| ||JH / MS
−
|PENDING
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
 
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
 
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
Line 361: Line 405:
 
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
 
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
 
|
 
|
−
|JH / MS
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|JH / MS
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
 
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
 
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
 
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
 
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
 
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
 
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|Need permission for figure?  Update WHO?
 
|Need permission for figure?  Update WHO?
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
 
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
 
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
 
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|Add WHO reference
 
|Add WHO reference
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
 
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
 
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
 
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
 
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
−
| ||JH / MS
 
−
|Complete
 
 
|
 
|
 +
|
 +
|Complete
 +
| ||JH / MS
 
|
 
|
 
|Check reference format
 
|Check reference format
 
|-
 
|-
 
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
 
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
 
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
 
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
 
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
 
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
 
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
 
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
 
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
 
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
 
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
 
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
 
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
−
| ||JH / MS
 
−
|Complete
 
 
|
 
|
 +
|
 +
|Complete
 +
| ||JH / MS
 
|
 
|
 
|Need permission for figure?
 
|Need permission for figure?
 
|-
 
|-
 
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
 
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
 
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
 
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
 
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
 
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|Check reference format
 
|Check reference format
 
|-
 
|-
 
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
 
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
 
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
 
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|Check reference format
 
|Check reference format
 
|-
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
 
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
 +
|
 +
|
 +
|Complete
 
| ||JH / MS
 
| ||JH / MS
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease||
 
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease||
 +
|
 +
|
 +
|??
 
| ||JH / MS
 
| ||JH / MS
−
|??
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||
 
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||
 +
|
 +
|
 +
|??
 
| ||JH / MS
 
| ||JH / MS
−
|??
 
−
|
 
 
|
 
|
 
|
 
|
Line 623: Line 704:
 
|Kay Weng Choy + Greg Conboy (Monash Health)
 
|Kay Weng Choy + Greg Conboy (Monash Health)
 
|
 
|
−
|JH / MS
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|JH / MS
 
|
 
|
 
|NON-WHO ENTITY
 
|NON-WHO ENTITY
Line 633: Line 715:
 
|Daynna Wolff+Jessica Snider (Path Resident)
 
|Daynna Wolff+Jessica Snider (Path Resident)
 
|
 
|
−
|JH / MS
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|JH / MS
 
|
 
|
 
|NON-WHO ENTITY
 
|NON-WHO ENTITY
Line 643: Line 726:
 
|Daynna Wolff+ Paige Woodham (Path Resident)
 
|Daynna Wolff+ Paige Woodham (Path Resident)
 
|
 
|
−
|JH / MS
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|JH / MS
 
|
 
|
 
|NON-WHO ENTITY
 
|NON-WHO ENTITY
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
 
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
−
| ||Yassmine Akkari (YA)
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||Yassmine Akkari (YA)
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
 
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||
 
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
Line 679: Line 767:
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
 
|
 
|
−
|YA
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|YA
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||
 
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
Line 703: Line 794:
 
Lisa Smith + Yassmine Akkari
 
Lisa Smith + Yassmine Akkari
 
|
 
|
−
|YA
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|YA
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
Line 725: Line 819:
 
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
 
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
 
|
 
|
−
|YA
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|YA
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||
 
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
 
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
 
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
 
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
 
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
−
| ||YA
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||YA
 
|
 
|
 
|
 
|
Line 770: Line 870:
 
|Helene Bruyere
 
|Helene Bruyere
 
|
 
|
−
|YA
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|YA
 
|
 
|
 
|NON-WHO ENTITY
 
|NON-WHO ENTITY
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
 
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
−
| ||Snehal Patel (SP)
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||Snehal Patel (SP)
 
|
 
|
 
|
 
|
Line 792: Line 895:
 
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
 
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 800: Line 904:
 
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
 
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 808: Line 913:
 
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
 
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 816: Line 922:
 
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
 
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
 
|
 
|
−
|SP
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|SP
 
|
 
|
 
|Malini to review
 
|Malini to review
Line 824: Line 931:
 
|Hairy Cell Leukemia||Disease||Snehal Patel
 
|Hairy Cell Leukemia||Disease||Snehal Patel
 
|
 
|
−
|SP
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|SP
 
|
 
|
 
|Malini to review
 
|Malini to review
Line 832: Line 940:
 
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
|
 
|
−
|SP
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|SP
 
|
 
|
 
|Malini to review
 
|Malini to review
Line 840: Line 949:
 
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
|
 
|
−
|SP
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|SP
 
|
 
|
 
|Malini to review
 
|Malini to review
Line 848: Line 958:
 
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
 
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
 
|
 
|
−
|SP
+
|
 
|Complete
 
|Complete
 
|
 
|
 +
|SP
 
|
 
|
 
|Malini to review
 
|Malini to review
Line 856: Line 967:
 
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
 
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 864: Line 976:
 
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
 
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
 
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
 
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Mu Heavy Chain  Disease||Disease||
 
|    Mu Heavy Chain  Disease||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Gamma Heavy Chain  Disease||Disease||
 
|   Gamma Heavy Chain  Disease||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Alpha Heavy Chain  Disease||Disease||
 
|    Alpha Heavy Chain  Disease||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
Line 907: Line 1,025:
 
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
 
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 915: Line 1,034:
 
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
 
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 923: Line 1,043:
 
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
 
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 931: Line 1,052:
 
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
 
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 939: Line 1,061:
 
|    Plasmacytoma||Disease||Zhenya Tang
 
|    Plasmacytoma||Disease||Zhenya Tang
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
 
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|           Primary  Amyloidosis||Disease||
 
|           Primary  Amyloidosis||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
 
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
 
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|         POEMS Syndrome||Disease||
 
|         POEMS Syndrome||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|         TEMPI Syndrome||Disease||
 
|         TEMPI Syndrome||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
Line 989: Line 1,118:
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Nodal Marginal Zone Lymphoma||Disease||
 
|Nodal Marginal Zone Lymphoma||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
Line 1,004: Line 1,135:
 
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,012: Line 1,144:
 
|Follicular Lymphoma||Disease||Ruthann Pfau
 
|Follicular Lymphoma||Disease||Ruthann Pfau
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,020: Line 1,153:
 
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
 
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,028: Line 1,162:
 
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
 
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,036: Line 1,171:
 
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
 
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,044: Line 1,180:
 
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||
 
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Primary Cutaneous Follicle Centre Lymphoma||Disease||
 
|Primary Cutaneous Follicle Centre Lymphoma||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
Line 1,066: Line 1,205:
 
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|
 
|
−
|SP
+
|
 
|PENDING - due 8/15/20
 
|PENDING - due 8/15/20
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,074: Line 1,214:
 
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|
 
|
−
|SP
+
|
 
|PENDING - due 8/31/20
 
|PENDING - due 8/31/20
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,082: Line 1,223:
 
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
 
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
 
|
 
|
−
|SP
+
|
 
|PENDING - due 8/15/20
 
|PENDING - due 8/15/20
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
Line 1,097: Line 1,240:
 
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
 
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
 
|
 
|
−
|Greg Corboy (GC)
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|Greg Corboy (GC)
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
 
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
 
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
 
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
 
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|EBV-Positive Mucocutaneous Ulcer||Disease||
 
|EBV-Positive Mucocutaneous Ulcer||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
 
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
 
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Lymphomatoid Granulomatosis||Disease||
 
|Lymphomatoid Granulomatosis||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
 
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Intravascular Large B-cell Lymphoma||Disease||
 
|Intravascular Large B-cell Lymphoma||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|ALK-Positive Large B-cell Lymphoma||Disease||
 
|ALK-Positive Large B-cell Lymphoma||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
 
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
 +
|
 +
|
 +
|Complete
 
| ||GC
 
| ||GC
−
|Complete
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Primary Effusion Lymphoma||Disease||
 
|Primary Effusion Lymphoma||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
 
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Multicentric Castleman  Disease||Disease||
 
|   Multicentric Castleman  Disease||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
 
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
 
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Burkitt Lymphoma||Disease||
 
|Burkitt Lymphoma||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
 
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
 
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
 
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
 
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
 
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
−
| ||GC
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||GC
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
 
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
−
| ||Snehal Patel (SP)
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||Snehal Patel (SP)
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
 
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
 +
|
 +
|
 +
|PENDING
 
| ||SP
 
| ||SP
−
|PENDING
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
 
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
−
| ||SP
 
−
|PENDING
 
 
|
 
|
 +
|
 +
|PENDING
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
 
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
 +
|
 +
|
 +
|PENDING
 
| ||SP
 
| ||SP
−
|PENDING
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Aggressive NK-cell Leukemia||Disease||
 
|Aggressive NK-cell Leukemia||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
 
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||
 
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
 
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
 
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Severe Mosquito Bite  Allergy||Disease||
 
|    Severe Mosquito Bite  Allergy||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Adult T-cell Leukemia/Lymphoma||Disease||
 
|Adult T-cell Leukemia/Lymphoma||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
 
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
Line 1,357: Line 1,537:
 
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
 
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,365: Line 1,546:
 
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,373: Line 1,555:
 
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
 
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,381: Line 1,564:
 
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,389: Line 1,573:
 
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
 
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
 +
|
 +
|
 +
|PENDING
 
| ||SP
 
| ||SP
−
|PENDING
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
 
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Mycosis Fungoides||Disease||
 
|Mycosis Fungoides||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Sézary Syndrome||Disease||
 
|Sézary Syndrome||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
 
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Lymphomatoid  Papulosis||Disease||
 
|    Lymphomatoid  Papulosis||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
 
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
 
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
 
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
 
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
 
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
 
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
 
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
 
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
Line 1,495: Line 1,694:
 
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,503: Line 1,703:
 
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||
 
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||
−
| ||SP
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||SP
 
|
 
|
 
|
 
|
Line 1,518: Line 1,720:
 
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
 
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,526: Line 1,729:
 
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
 
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
Line 1,534: Line 1,738:
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
 
|
 
|
−
|SP
+
|
 
|PENDING
 
|PENDING
 
|
 
|
 +
|SP
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
 
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
−
| ||Associate Editor??
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||Associate Editor??
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
 
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
 
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
 
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
 
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
 
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
 
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
 
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Lymphomas Associated with HIV Infection||Disease||
 
|Lymphomas Associated with HIV Infection||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
 
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
 
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
Line 1,630: Line 1,847:
 
|
 
|
 
|PENDING
 
|PENDING
 +
|
 
|
 
|
 
|
 
|
Line 1,635: Line 1,853:
 
|-
 
|-
 
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
 
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|          Monomorphic  B-cell PTLD||Disease||
 
|          Monomorphic  B-cell PTLD||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|          Monomorphic  T/NK-cell PTLD||Disease||
 
|          Monomorphic  T/NK-cell PTLD||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
 
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
 
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
 
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Histiocytic Sarcoma||Disease||
 
|Histiocytic Sarcoma||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
 
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Langerhans Cell  Histiocytosis||Disease||
 
|   Langerhans Cell  Histiocytosis||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|   Langerhans Cell  Sarcoma||Disease||
 
|   Langerhans Cell  Sarcoma||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Indeterminate Dendritic Cell Tumour||Disease||
 
|Indeterminate Dendritic Cell Tumour||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Interdigitating Dendritic Cell Sarcoma||Disease||
 
|Interdigitating Dendritic Cell Sarcoma||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Follicular Dendritic Cell Sarcoma||Disease||
 
|Follicular Dendritic Cell Sarcoma||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
 
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Fibroblastic Reticular Cell Tumor||Disease||
 
|Fibroblastic Reticular Cell Tumor||Disease||
−
| ||
 
 
|
 
|
 
|
 
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Disseminated Juvenile Xanthogranuloma||Disease||
 
|Disseminated Juvenile Xanthogranuloma||Disease||
 +
|
 +
|
 +
|
 
| ||
 
| ||
 
|
 
|
 
|
 
|
 +
|-
 +
|Erdheim-Chester Disease||Disease||
 +
|
 +
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Erdheim-Chester Disease||Disease||
+
| || ||
 +
|
 +
|
 +
|
 
| ||
 
| ||
 
|
 
|
 
|
 
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
−
|
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
| || ||
 
 
| ||
 
| ||
−
|
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|-
 
−
| || ||
 
 
| ||
 
| ||
−
|
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|-
 
−
| || ||
 
 
| ||
 
| ||
−
|
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
−
|
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
| || ||
 
 
| ||
 
| ||
−
|
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
−
|
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
| || ||
 
 
| ||
 
| ||
−
|
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
−
|
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
| || ||
 
 
| ||
 
| ||
−
|
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|-
 
−
| || ||
 
 
| ||
 
| ||
−
|
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|-
 
−
| || ||
 
 
| ||
 
| ||
−
|
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
−
|
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
| || ||
 
 
| ||
 
| ||
−
|
 
−
|
 
 
|
 
|
 
|
 
|
 
|-
 
|-
 
| || ||
 
| || ||
−
| ||
 
−
|
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
| || ||
 
 
| ||
 
| ||
−
|
 
−
|
 
 
|
 
|
 
|
 
|

Revision as of 13:18, 7 August 2020

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content Pending or Complete Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myeloproliferative Neoplasms (MPN) Overview Mark Evans (trainee), Fabiola Quintero-Rivera PENDING Fabiola Quintero-Rivera (FQR)
    Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive Disease Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera Complete FQR
    Chronic Neutrophilic Leukemia (CNL) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera PENDING FQR
    Polycythaemia Vera (PV) Disease Gokce A. Toruner PENDING FQR
    Primary Myelofibrosis (PMF) Disease T. Niroshi Senaratne PENDING FQR
    Essential Thrombocythaemia (ET) Disease Rebecca Smith (trainee) + faculty TBD PENDING FQR
    Chronic Eosinophilic Leukemia, Not Otherwise Specified Disease Mark Evans (trainee), Fabiola Quintero-Rivera PENDING FQR
    Myeloproliferative Neoplasm (MPN), Unclassifiable Disease Mark Evans (trainee)+ Fabiola Quintero-Rivera PENDING FQR
Mastocytosis Overview FQR
    Cutaneous Mastocytosis Disease Thuy Phung PENDING FQR
    Systemic Mastocytosis Disease Shashi Shetty PENDING FQR
    Mast Cell Sarcoma Disease Thuy Phung PENDING FQR
Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 Overview Daynna J.Wolff PENDING FQR
    Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement Disease Jay Alden (trainee) +Daynna J.Wolff Complete FQR
    Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement Disease Christopher Sullivan (trainee) + Daynna J.Wolff Complete FQR
    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement Disease Yanna Ding Complete FQR
    Myeloid/Lymphoid Neoplasms with PCM1-JAK2 Disease Jessica Snider (trainee) + Daynna J.Wolff Complete FQR
Myeloid/Lymphoid Neoplasms with ETV6-JAK2 Disease Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff Complete FQR NON-WHO ENTITY
Myeloid/Lymphoid Neoplasms with BCR-JAK2 Disease Lauren R. Crowson (trainee) + Daynna J. Wolff Complete FQR NON-WHO ENTITY
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) Overview Linsheng Zhang Complete FQR
    Chronic Myelomonocytic Leukemia (CMML) Disease Linsheng Zhang Complete FQR
    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative Disease Linsheng Zhang Complete FQR
    Juvenile Myelomonocytic Leukemia (JMML) Disease Sarah Rapisardo PENDING FQR
    Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera PENDING FQR
    Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable Disease Ruth MacKinnon PENDING FQR
Myelodysplastic Syndromes (MDS) Overview Teresa Smolarek? FQR
    Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia Disease Xiaoli Du(trainee) +Teresa Smolarek PENDING FQR
    Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS) Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia Disease Xiaoli Du(trainee)+Teresa Smolarek PENDING FQR
    Myelodysplastic Syndrome (MDS) with Excess Blasts Disease Xiaoli Du(trainee)+Teresa Smolarek PENDING FQR
    Myelodysplastic Syndrome (MDS) with Isolated del(5q) Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome (MDS), Unclassifiable Disease Xiaolin Hu(trainee)+Teresa Smolarek PENDING FQR
    Refractory Cytopenia of Childhood Disease Xiaoli Du(trainee)+Teresa Smolarek PENDING FQR
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms Overview Daynna Wolff+Daniel Butler (Path Resident) Complete Jennelle Hodge (JH)/ Malini Sathanoori (MS)
Myeloid Neoplasms with Germline Predisposition Overview Ying Zou Complete JH / MS
    Acute Myeloid Leukaemia with Germline CEBPA Mutation Disease Daynna Wolff+Matthew Kilpatrick (Path Resident) PENDING JH / MS
    Myeloid Neoplasms with Germline DDX41 Mutation Disease Fei Yang PENDING JH / MS
    Myeloid Neoplasms with Germline RUNX1 Mutation Disease Malini Sathanoori PENDING JH / MS
    Myeloid Neoplasms with Germline ANKRD26 Mutation Disease Fei Yang PENDING JH / MS
    Myeloid Neoplasms with Germline ETV6 Mutation Disease Ying Zou Complete JH / MS
    Myeloid Neoplasms with Germline GATA2 Mutation Disease Daynna Wolff+ Alexandria Avery (Path Resident) Complete JH / MS
Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities Overview Daynna Wolff+ Dan Wang (trainee) Complete JH / MS
    Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 Disease Christine Bryke Complete JH / MS
    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Disease Christine Bryke Complete JH / MS
    Acute Promyelocytic Leukemia (APL) with PML-RARA Disease Shashi Shetty Complete JH / MS
    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 Disease Shashi Shetty Complete JH / MS
    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM Disease Gordana Raca Complete JH / MS Need permission for figure? Update WHO?
    Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with BCR-ABL1 Disease Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS
    Acute Myeloid Leukemia (AML) with Mutated NPM1 Disease Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS Add WHO reference
    Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA Disease Paul deFazio, MSc + Greg Conboy (Monash Health) Complete JH / MS
    Acute Myeloid Leukemia (AML) with Mutated RUNX1 Disease Daynna Wolff+Iris Martin (Path Resident) Complete JH / MS
Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes Disease Fei Yang Complete JH / MS
Therapy-Related Myeloid Neoplasms Disease Shashi Shetty + Shawn A. Silver (resident) Complete JH / MS Check reference format
Acute Myeloid Leukemia (AML), Not Otherwise Specified Overview Anwar Iqbal Complete JH / MS
    Acute Myeloid Leukemia (AML) with Minimal Differentiation Disease Fabiola Quintero-Rivera and Celeste Eno (fellow) Complete JH / MS
   Acute Myeloid Leukemia (AML) without Maturation Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with Maturation Disease Jennelle Hodge Complete JH / MS
    Acute Myelomonocytic Leukemia Disease Fei Yang Complete JH / MS
    Acute Monoblastic and Monocytic Leukemia Disease Fei Yang Complete JH / MS
    Pure Erythroid Leukemia Disease Ash Yenamandra Complete JH / MS
    Acute Megakaryoblastic Leukemia (AMKL) Disease Fei Yang Complete JH / MS
    Acute Basophilic Leukemia Disease Ash Yenamandra Complete JH / MS
    Acute Panmyelosis with Myelofibrosis Disease Ying Zou and Jialing Huang (MGP fellow) Complete JH / MS
Myeloid Sarcoma Disease Fabiola Quintero-Rivera Complete JH / MS
Myeloid Proliferations Associated with Down Syndrome Overview Patty Greipp Complete JH / MS Need permission for figure?
    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome Disease Linda Cooley Complete JH / MS
    Myeloid Leukemia Associated with Down Syndrome Disease Linda Cooley Complete JH / MS
Blastic Plasmacytoid Dendritic Cell Neoplasm Disease Daynna Wolff+Hao Liu (Path Resident) Complete JH / MS
Acute Leukemias of Ambiguous Lineage Overview Hui Chen/ Jennelle Hodge Complete JH / MS
    Acute Undifferentiated Leukemia Disease Shashi Shetty + Amelia Nakanishi (resident) Complete JH / MS Check reference format
    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 Disease Tracy Tucker Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged Disease Tracy Tucker Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified Disease Shashi Shetty + Priyatharsini Nirmalanantham (resident) Complete JH / MS Check reference format
    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified Disease Fabiola Quintero-Rivera Complete JH / MS
    ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types Disease ?? JH / MS
    ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS) Disease ?? JH / MS
Acute Myeloid Leukemia (AML) with Mutated FLT3 Disease Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with NUP214-ABL1 Disease Daynna Wolff+Jessica Snider (Path Resident) PENDING JH / MS NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 Disease Daynna Wolff+ Paige Woodham (Path Resident) PENDING JH / MS NON-WHO ENTITY
Precursor Lymphoid Neoplasms Overview Yassmine Akkari (YA)
B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities Overview YA
    B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1     Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged Disease Yassmine Akkari+Nicolas Millan (trainee) PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy Disease Ashwini Yenamandra +

Lisa Smith + Yassmine Akkari

Complete YA
    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like Disease Mark G. Evans + Fabiola Quintero-Rivera Complete YA
    B-Lymphoblastic Leukemia/Lymphoma with iAMP21 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified Disease YA
T-Lymphoblastic Leukemia/Lymphoma Overview YA
Early T-Cell Precursor Lymphoblastic Leukemia Disease YA
NK-Lymphoblastic Leukemia/Lymphoma Disease YA
B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements Disease Helene Bruyere PENDING YA NON-WHO ENTITY
Mature B-Cell Neoplasms Overview Snehal Patel (SP)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Disease Honey Reddi PENDING SP
       Monoclonal B-cell Lymphocytosis Disease Honey Reddi PENDING SP
B-cell Prolymphocytic Leukemia Disease Honey Reddi PENDING SP
Splenic Marginal Zone Lymphoma Disease Snehal Patel Complete SP Malini to review
Hairy Cell Leukemia Disease Snehal Patel Complete SP Malini to review
Splenic B-cell Lymphoma/Leukemia, Unclassifiable Overview Snehal Patel Complete SP Malini to review
    Splenic Diffuse Red Pulp Small B-cell Lymphoma Disease Snehal Patel Complete SP Malini to review
    Hairy Cell Leukemia Variant Disease Snehal Patel Complete SP Malini to review
Lymphoplasmacytic Lymphoma Disease Honey Reddi PENDING SP
   Waldenstrom Macroglobulinemia Disease Honey Reddi PENDING SP
IgM Monoclonal Gammopathy of Undetermined Significance Disease SP
Heavy Chain Diseases Overview SP
    Mu Heavy Chain Disease Disease SP
   Gamma Heavy Chain Disease Disease SP
    Alpha Heavy Chain Disease Disease SP
Plasma Cell Neoplasms Overview Zhenya Tang PENDING SP
   Non-IgM Monoclonal Gammopathy of Undetermined Significance Disease Zhenya Tang PENDING SP
    Plasma Cell Myeloma Disease Zhenya Tang/Huang Mo (trainee) PENDING SP
    Plasma Cell Myeloma Variants Disease Zhenya Tang PENDING SP
    Plasmacytoma Disease Zhenya Tang PENDING SP
    Monoclonal Immunoglobulin Deposition Diseases Overview SP
           Primary Amyloidosis Disease SP
           Light Chain and Heavy Chain Deposition Disease Disease SP
Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome Overview SP
         POEMS Syndrome Disease SP
         TEMPI Syndrome Disease SP
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) Disease Zhenya Tang & Trainee PENDING SP
Nodal Marginal Zone Lymphoma Disease SP
    Paediatric Nodal Marginal Zone Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) PENDING SP
Follicular Lymphoma Disease Ruthann Pfau PENDING SP
    Testicular Follicular Lymphoma Disease Ruthann Pfau PENDING SP
    In Situ Follicular Neoplasia Disease Ruthann Pfau PENDING SP
    Duodenal-Type Follicular Lymphoma Disease Ruthann Pfau PENDING SP
Paediatric-Type Follicular Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) PENDING SP
Large B-cell Lymphoma with IRF4 Rearrangement Disease SP
Primary Cutaneous Follicle Centre Lymphoma Disease SP
Mantle Cell Lymphoma Disease Mahsa Khanlari PENDING - due 8/15/20 SP
    Leukemic Non-Nodal Mantle Cell Lymphoma Disease Mahsa Khanlari PENDING - due 8/31/20 SP
    In Situ Mantle Cell Neoplasia Disease Mahsa Khanlari PENDING - due 8/15/20 SP
Diffuse Large B-cell Lymphoma, Not Otherwise Specified Disease Ashwini Yenamandra PENDING Greg Corboy (GC)
T-cell/Histiocyte-Rich Large B-cell Lymphoma Disease GC
Primary Diffuse Large B-cell Lymphoma of the CNS Disease GC
Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type Disease GC
EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
EBV-Positive Mucocutaneous Ulcer Disease GC
Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation Disease GC
    Fibrin-Associated Diffuse Large B-cell Lymphoma Disease GC
Lymphomatoid Granulomatosis Disease GC
Primary Mediastinal (Thymic) Large B-cell Lymphoma Disease GC
Intravascular Large B-cell Lymphoma Disease GC
ALK-Positive Large B-cell Lymphoma Disease GC
Plasmablastic Lymphoma Disease Mark Evans (trainee), Fabiola Quintero-Rivera Complete GC
Primary Effusion Lymphoma Disease GC
HHV8-Associated Lymphoproliferative Disorders Overview GC
   Multicentric Castleman Disease Disease GC
   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
   HHV8-Positive Germinotropic Lymphoproliferative Disorder Disease GC
Burkitt Lymphoma Disease GC
Burkitt-Like Lymphoma with 11q Aberration Disease GC
High-Grade B-cell Lymphoma Overview GC
    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Disease GC
    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma Disease GC
Mature T- and NK-cell Neoplasms Overview Snehal Patel (SP)
T-cell Prolymphocytic Leukemia Disease Michelle Don PENDING SP
T-cell Large Granular Lymphocytic Leukemia Disease Michelle Don PENDING SP
Chronic Lymphoproliferative Disorder of NK Cells Disease Michelle Don PENDING SP
Aggressive NK-cell Leukemia Disease SP
EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood Overview SP
  Systemic EBV-Positive T-cell Lymphoma of Childhood Disease SP
   Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form Disease SP
    Hydroa Vacciniforme-Like Lymphoproliferative Disorder Disease SP
    Severe Mosquito Bite Allergy Disease SP
Adult T-cell Leukemia/Lymphoma Disease SP
Extranodal NK/T-cell Lymphoma, Nasal Type Disease SP
Intestinal T-cell Lymphoma Overview Sumire Kitahara, Derick Okwan (trainee) PENDING SP
    Enteropathy-Associated T-cell Lymphoma Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Disease Sumire Kitahara PENDING SP
     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
Hepatosplenic T-cell Lymphoma Disease Michelle Don PENDING SP
Subcutaneous Panniculitis-Like T-cell Lymphoma Disease SP
Mycosis Fungoides Disease SP
Sézary Syndrome Disease SP
Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders Overview SP
    Lymphomatoid Papulosis Disease SP
    Primary Cutaneous Anaplastic Large Cell Lymphoma Disease SP
Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes Overview SP
     Primary Cutaneous Gamma Delta T-cell Lymphoma Disease SP
     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Disease SP
     Primary Cutaneous Acral CD8+ T-cell Lymphoma Disease SP
     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder Disease SP
Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS) Disease SP
Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin Overview SP
     Angioimmunoblastic T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) PENDING SP
    Follicular T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) PENDING SP
     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype Disease SP
Anaplastic Large Cell Lymphoma, ALK-Positive Disease Sumire Kitahara PENDING SP
Anaplastic Large Cell Lymphoma, ALK-Negative Disease Sumire Kitahara PENDING SP
Breast Implant-Associated Anaplastic Large Cell Lymphoma Disease Sumire Kitahara PENDING SP
Hodgkin Lymphomas Overview Associate Editor??
Nodular Lymphocyte Predominant Hodgkin Lymphoma Disease
Classic Hodgkin Lymphoma Overview
    Nodular Sclerosis Classic Hodgkin Lymphoma Disease
    Lymphocyte-Rich Classic Hodgkin Lymphoma Disease
    Mixed Cellularity Classic Hodgkin Lymphoma Disease
    Lymphocyte-Depleted Classic Hodgkin Lymphoma Disease
Immunodeficiency-Associated Lymphoproliferative Disorders Overview
Lymphomas Associated with HIV Infection Disease
Post-Transplant Lymphoproliferative Disorders Overview
    Non-Destructive Post-Transplant Lymphoproliferative Disorders Disease
    Polymorphic Post-Transplant Lymphoproliferative Disorders Disease Anna Shestakova (trainee)+,

Fabiola Quintero-Rivera

PENDING
    Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types) Overview
          Monomorphic B-cell PTLD Disease
          Monomorphic T/NK-cell PTLD Disease
    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder Disease
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders Disease
Histiocytic and Dendritic Cell Neoplasms Overview
Histiocytic Sarcoma Disease
Tumors Derived From Langerhans Cells Overview
   Langerhans Cell Histiocytosis Disease
   Langerhans Cell Sarcoma Disease
Indeterminate Dendritic Cell Tumour Disease
Interdigitating Dendritic Cell Sarcoma Disease
Follicular Dendritic Cell Sarcoma Disease
    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma Disease
Fibroblastic Reticular Cell Tumor Disease
Disseminated Juvenile Xanthogranuloma Disease
Erdheim-Chester Disease Disease
Gene-Specific Pages
Gene Author Associate Editor Author Content

(Pending or Complete)

Editor Reviewed (Date) Notes
BCR Brian Davis Complete (8/10/18)
ABL1 Brian Davis Complete (4/16/19)
RUNX1 Brian Davis Complete (6/9/19)
RUNX1T1 Brian Davis Complete (5/23/19)
MYH11 Brian Davis Complete (8/6/18)
FLT3 Kay Weng Choy Complete (
NPM1 Kay Weng Choy Complete (
TP53 Kay Weng Choy Complete (
DNMT3A Kay Weng Choy Complete (
CEBPA Gordana Complete (
IDH1 Paul De Fazio Complete (
IDH2 Paul De Fazio Complete (
PML Brian Davis Complete (12/5/18)
RARA Brian Davis Complete (8/3/18)
ETV6 Brian Davis Complete (6/9/19)
KIT Brian Davis Complete (10/1/18)
CBFB Brian Davis Complete (8/2/18)
GATA2 Kay Weng Choy Complete (
PTEN Beth Pitel Pending
MLTT3
MECOM Brian Davis Pending
FGFR1(FLT2) Brian Davis Pending
KMT2A
DEK
NUP214
RBM15
MKL1
DDX41
ANKRD26
CUX1
TET2
EZH2
FOXP1
MYC
JAK2
WT1
CBL
NF1
SUZ12
ERG
EST2
RPS14
RB1
MPL
CHGA
CDH1
SRSF2
DNMT1
PRDX2
ASXL1
MN1
SF3A1
EP300
JARID2
Retrieved from "https://ccga.io/index.php?title=Volunteer_Assignments_and_Opportunities&oldid=8659"